share_log

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

为什么 NLS Pharmacetics 股价下跌超过 66%;以下是昨天以来的 68 个最大涨幅
Benzinga Real-time News ·  2022/09/29 05:11
Gainers
获胜者
PepGen Inc. (NASDAQ:PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint. Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares rose 103.8% to close at $9.58 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint. Prothena Corporation plc (NASDAQ:PRTA) shares jumped 87.5% to close at $58.00 on Wednesday after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate. Prothena is a biotechnology company that focuses on protein...
PepGen Inc. 纳斯达克股票代码:PEPG)上涨110.2%,收于10.93美元,此前该公司公布了杜兴氏肌肉萎缩症 PGN-EDO51 的1期健康志愿者试验的结果。该试验达到了其主要终点。 ...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发